Open Access
Review
Multifunctional nanoparticles in colorectal cancer therapy: Advances in targeted drug delivery systems
Vis Cancer Med, 7 (2026) 3
Published online: 09 June 2026
Visualized Cancer Medicine
Visualized Cancer Medicine is an interdisciplinary and peer-reviewed journal, which publishes the advances in basic, translational, and clinical studies on cancer biology, cancer prevention, cancer screening and diagnosis, cancer treatments, and cancer patient rehabilitation, with an emphasis on videos presenting the natural process, interventional procedure, and spatial alteration of the studied objects.
Visualized Cancer Medicine is the official journal of the Society of Tumor Microenvironment, China Anti-Cancer Association.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
-
-
Open Access
Oral carcinoma cuniculatum: A rare entity with diagnostic challenges. A series of 5 cases and review of literature
Vis Cancer Med, 7 (2026) 2Published online: 20 April 2026 -
Open AccessEditorial
Interwoven control of histone lactylation: metabolic enzymes LDHA/ACSS2 couple with epigenetic writer KAT2A
Vis Cancer Med, 7 (2026) E1Published online: 13 March 2026 -
Open Access
Diagnostic experiences of patients with cervical cancer: A qualitative study in Accra Metropolis, Ghana
Vis Cancer Med, 7 (2026) 1Published online: 18 February 2026 -
Open AccessReview
From single-cell snapshots to spatial panoramas – a holistic multiomics map of glioblastoma
Vis Cancer Med, 6 (2025) 15Published online: 09 January 2026 -
Open AccessErratum
Corrigendum to: Loss of monoacylglycerol O-acyltransferase 2 can be compensated for by diacylglycerol O-acyltransferases 1 and 2 resulting in a negligible influence on mammary cancer development found in a mouse model and verified in human tissues
Vis Cancer Med, 6 (2025) 14Published online: 24 November 2025 -
Open Access
Hepatic parenchymal resection with waterjet in the malignant setting – Results of an Initial Foray
Vis Cancer Med, 6 (2025) 13Published online: 15 September 2025 -
Open AccessReview
m6A modification in cancer regulation: molecular circuits and regulatory networks
Vis Cancer Med, 6 (2025) 12Published online: 13 August 2025
| 770 |
Open Access
Review
Metastasis of nasopharyngeal carcinoma: What we know and do not knowVis Cancer Med, 2 (2021) 4
Published online: 11 August 2021
|
| 406 |
Open Access
The next steps for chemo-optimization in lung cancer treatmentVis Cancer Med, 6 (2025) 8
Published online: 11 June 2025
|
| 381 |
Open Access
Review
Comparison of cyclotron and synchrotron in particle therapyVis Cancer Med, 5 (2024) 7
Published online: 31 July 2024
|
| 292 |
Open Access
Review
Recent progress in the treatment of locally advanced head and neck squamous cell carcinomasVis Cancer Med, 6 (2025) 11
Published online: 04 August 2025
|
| 247 |
Open Access
Review
Roles of heat shock proteins in tumor immune microenvironmentVis Cancer Med, 5 (2024) 3
Published online: 16 February 2024
|
| 20 |
Open Access
Review
Functions of glutaminyl cyclase and its isoform in diseasesVis Cancer Med, 4 (2023) 1
Published online: 06 January 2023
|
| 16 |
Open Access
Review
Metastasis of nasopharyngeal carcinoma: What we know and do not knowVis Cancer Med, 2 (2021) 4
Published online: 11 August 2021
|
| 14 |
Open Access
An increase in early cancer detection rates at a single cancer center: Experiences from Sun Yat-sen University Cancer CenterVis Cancer Med, 3 (2022) 1
Published online: 01 March 2022
|
| 11 |
Open Access
Spatially-resolved proteomics and transcriptomics: An emerging digital spatial profiling approach for tumor microenvironmentVis Cancer Med, 2 (2021) 1
Published online: 03 March 2021
|
| 9 |
Open Access
Review
Updates on altered signaling pathways in tumor drug resistanceVis Cancer Med, 5 (2024) 6
Published online: 22 July 2024
|
